Cetera Investment Advisers
VCYT icon

Cetera Investment Advisers’s Veracyte VCYT Stock Holding History

Cetera Investment Advisers’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$275K Sell
8,529
-782
-8% -$28.9K ﹤0.01% 4061
2025
Q4 		$392K Buy
9,311
+120
+1% +$4.84K ﹤0.01% 3655
2025
Q3 		$316K Buy
+9,191
New +$264K ﹤0.01% 3785

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Cetera Investment Advisers's VCYT Position: Q1 2026 in Review

Cetera Investment Advisers reduced its Veracyte (VCYT) stake by 8.4% in Q1 2026, selling an estimated $28.9K and leaving 8,529 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #4061.

Cetera Investment Advisers first reported a position in VCYT in Q3 2025 and has held it in 3 quarters since. The position peaked at $392K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Cetera Investment Advisers held 8,529 shares of Veracyte worth $275K as of Q1 2026.
  • Cetera Investment Advisers sold 782 Veracyte shares in Q1 2026, an estimated $28.9K.
  • Veracyte made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4061 holding.
  • Cetera Investment Advisers first reported a position in Veracyte in Q3 2025 and has held it in 3 quarters since.
  • Cetera Investment Advisers's Veracyte position peaked at $392K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.